A mosquito-borne disease associated with birth defects. Since 1952, Zika outbreaks have been reported in tropical Africa, Southeast Asia, the Pacific Islands, and, in 2015, in the Americas. According to the WHO, there is scientific consensus that Zika virus (ZIKV) is a cause of microcephaly and Guillain-Barré syndrome.

VLA1601 – Valneva’s Zika virus development program

  • VLA1601 is a highly purified inactivated vaccine candidate against the Zika virus.
  • It was developed using the same manufacturing platform as Valneva’s Japanese encephalitis vaccine.


Additional information about Zika: